Original Research
Published on 28 Nov 2022
A prognostic signature based on adenosine metabolism related genes for ovarian cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1003512
- 2,685 views
- 1 citation
Type at least 3 characters
906 articles
Articles
Original Research
Published on 25 Nov 2022
Dinaciclib as an effective pan-cyclin dependent kinase inhibitor in platinum resistant ovarian cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1014280
- 3,223 views
- 6 citations
Review
Published on 25 Nov 2022
Potential of histone deacetylase inhibitors for the therapy of ovarian cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1057186
- 2,903 views
- 4 citations
Original Research
Published on 24 Nov 2022
Prognostic analysis of pT1-T2aN0M0 cervical adenocarcinoma based on random survival forest analysis and the generation of a predictive nomogram
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1049097
- 1,948 views
- 4 citations
Original Research
Published on 24 Nov 2022
Zinc deficiency is associated with gynecologic cancer recurrence
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1025060
- 2,956 views
- 4 citations
Original Research
Published on 24 Nov 2022
Models including preoperative plasma levels of angiogenic factors, leptin and IL-8 as potential biomarkers of endometrial cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.972131
- 2,245 views
- 4 citations
Original Research
Published on 23 Nov 2022
Nomogram to predict postoperative complications after cytoreductive surgery for advanced epithelial ovarian cancer: A multicenter retrospective cohort study
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1052628
- 1,441 views
- 1 citation
Editorial
Published on 21 Nov 2022
Editorial: Molecular pathology and computational image analyses in gynecologic malignancies
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1082220
- 1,047 views
Original Research
Published on 15 Nov 2022
Large-cell neuroendocrine carcinoma of the gynecologic tract: Prevalence, survival outcomes, and associated factors
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.970985
- 2,384 views
- 6 citations
Review
Published on 11 Nov 2022
Utilization of functional MRI in the diagnosis and management of cervical cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1030967
- 3,608 views
- 8 citations
Original Research
Published on 09 Nov 2022
Circulating miR-326 could serve as a predictive biomarker for response to neoadjuvant chemotherapy in locally advanced cervical cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1036710
- 1,443 views
- 4 citations
Original Research
Published on 09 Nov 2022
Developing and validating a prognostic nomogram for ovarian clear cell carcinoma patients: A retrospective comparison of lymph node staging schemes with competing risk analysis
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.940601
- 2,687 views
- 3 citations
Original Research
Published on 09 Nov 2022
Monotherapy for low-risk gestational trophoblastic neoplasia with score 5-6
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1035170
- 1,961 views
- 2 citations
Opinion
Published on 09 Nov 2022
Imaging hypoxia in endometrial cancer: How and why should it be done?
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1020907
- 1,652 views
- 1 citation
Original Research
Published on 09 Nov 2022
Integrated bioinformatics analysis and experimental validation reveals fatty acid metabolism-related prognostic signature and immune responses for uterine corpus endometrial carcinoma
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1030246
- 1,964 views
- 1 citation
Original Research
Published on 08 Nov 2022
The effect of chemotherapy in patients with stage I mucinous ovarian cancer undergoing fertility-sparing surgery
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1028842
- 2,846 views
- 1 citation